Researchers at the University of Bergen in Norway have transformed skin puncture cells from diabetes patients into insulin-producing cells. Their aim is to transplant these cells under the skin of people with diabetes.
"This study is a step towards discovering how "stand-in" cells can secrete insulin in the body," said Helge Rader, professor at University of Bergen.
The researchers' goal is to replace insulin shots and blood sugar measurements with insulin-secreting cells capable of automatically secreting insulin in response to the blood sugar level.
"Our study is a step further in the spare part or regenerative medicine, where a lot may go wrong but where a successful approach may cure diabetes," Rader said.
There is an ongoing race between scientists trying to restore insulin secretion within the human body in diabetes patients, by artificially created insulin-producing cells.
"There is a big market out there for those who can commercialise successful treatment with this approach. Today 400 million people have diabetes worldwide," Rader added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
